EDMONTON, AB - Aurora Cannabis Inc. (NASDAQ: NASDAQ:ACB) (TSX: ACB), a leading global medical cannabis company based in Canada, has announced the repayment of roughly $7.2 million (US$5.3 million), which constitutes the final payment on the principal amount of its convertible senior notes. The total cash cost for this repayment, including accrued interest, was about $7.4 million (approximately US$5.5 million). With this move, Aurora has now settled nearly $465 million in convertible debt, leaving the company with a remaining debt of $47.9 million related to Bevo Farms Ltd.
Miguel Martin, CEO of Aurora, expressed that this repayment is a "significant milestone," highlighting the company's commitment to balance sheet strength and financial discipline. Martin anticipates these efforts will contribute to Aurora achieving its goal of positive free cash flow within the current calendar year.
Aurora Cannabis, with headquarters in Edmonton, Alberta, operates in the medical and consumer cannabis markets across Canada, Europe, Australia, and South America. The company boasts a diverse portfolio of adult-use brands such as Aurora Drift, San Rafael '71, and Daily Special, as well as medical cannabis brands like MedReleaf and CanniMed. Additionally, Aurora holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America.
The company's common shares are traded on the NASDAQ and TSX under the symbol "ACB" and it is part of the S&P/TSX Composite Index.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.